ADMA Biologics Dividends
| ADMA Stock | USD 17.52 0.02 0.11% |
At present, ADMA Biologics' Dividends Paid is projected to increase significantly based on the last few years of reporting. The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 13.08, whereas Dividend Yield is forecasted to decline to 0.07. ADMA Biologics' past performance could be the main factor of why investors trade ADMA Biologics stock today. Investors should clearly understand every aspect of the ADMA Biologics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest ADMA Biologics' dividend schedule and payout information. ADMA Biologics dividends can also provide a clue to the current valuation of ADMA Biologics.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 2.6 M | 2.7 M | |
| Dividend Yield | 0.08 | 0.07 | |
| Dividend Payout Ratio | (0.48) | (0.51) | |
| Dividend Paid And Capex Coverage Ratio | 12.46 | 13.08 |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in ADMA Biologics must own a stock before its ex-dividend date to receive its next dividend.
ADMA Biologics Dividends Paid Over Time
Today, most investors in ADMA Biologics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ADMA Biologics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ADMA Biologics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
ADMA Biologics Historical Dividend Yield Growth
A solid dividend growth pattern of ADMA Biologics could indicate future dividend growth is likely, which can signal long-term profitability for ADMA Biologics. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is ADMA Biologics dividend as a percentage of ADMA Biologics stock price. ADMA Biologics dividend yield is a measure of ADMA Biologics stock productivity, which can be interpreted as interest rate earned on an ADMA Biologics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ADMA Biologics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 0.81 | Revenue Per Share | Quarterly Revenue Growth 0.12 | Return On Assets | Return On Equity |
ADMA Biologics's market price often diverges from its book value, the accounting figure shown on ADMA's balance sheet. Smart investors calculate ADMA Biologics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ADMA Biologics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that ADMA Biologics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ADMA Biologics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.